
To own Houlihan Lokey, you have to buy into a fairly simple idea. This is an advisory firm that lives or dies on deal flow, pricing power on fees, and the ability to deploy senior talent where capital is actually moving. The West Palm Beach office, paired with the hires in New York and São Paulo, fits that story. It nudges the mix toward GP led secondaries, private capital solutions, and deeper sponsor relationships across the U.S. and Latin America rather than changing the whole business model overnight.
In the short term, the bigger swing factors still look like advisory volumes, fee pressure, and how efficiently Houlihan Lokey converts that activity into earnings. The stock has fallen about 35% over the past year, even with 12% annual revenue growth and 13.4% forecast earnings growth, which hints that investors remain cautious on execution and cycle risk. New leadership in Capital Solutions and Financial Sponsors slightly tilts catalysts toward mandate wins in secondaries and Latin America, while known pressure points such as a 22.8x P/E against a lower implied fair P/E and modestly lower profit margins do not go away.
That said, there is an awkward tension in the Houlihan Lokey story once you weigh its expansion push against ...
There's only one way to know the right time to buy, sell or hold Houlihan Lokey. Head to Simply Wall St's company report for the latest analysis of Houlihan Lokey's Fair Value.
One catalyst the most optimistic analysts highlight is Houlihan Lokey’s push into alternative assets and GP led secondaries. Before this West Palm Beach expansion, the bullish camp was already penciling in 14.8% annual revenue growth and earnings of US$593.7 million by about August 2029. You can treat those upbeat forecasts as one possible script that may evolve as this new office and senior hiring play out.
Explore 2 other Houlihan Lokey fair value estimates, including one that suggests there could be as much as 30% upside from the current price.
Disagree with this assessment? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
If the Houlihan Lokey story has sharpened your sense for where capital might move next, you can use that same lens across the wider market. The Simply Wall St Screener helps you scan for businesses that fit the kind of balance sheets, income profiles, and risk levels you want to focus on, rather than just chasing headlines.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com